To the central content area

Listed Companies

:::
:::Listed Companies > Listed Companies Info. > Emerging Stock Board Companies > Listed Company Profile

ESM Companies

For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
6748 ACRO Biomedical
中文
Basic information
Chairman President Spokesperson Telephone Address ESM Registration Date
HSIEH DAR JEN HSIEH DAR JEN TONY TSENG 07-6955569 2nd Fl., No. 57, Luke 2nd Rd., Lujhu Dist.Kaohsiung City 82151, Taiwan R.O.C. 2021/07/27
Industry
category
Key businesses
Biotechnology and Medical Care ACRO Biomedical focuses on research and development of biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). Tissue engineering and regenerative medicine combines three key elements: cell, signal, and scaffold. With the interaction of these three element, the defects or damages of tissues and organs can be repaired and reconstructed. The biomaterials prepared by ACRO’s proprietary supercritical CO2 technology serve a great purpose as scaffolds in one of three key elements, which provide the intact collagen scaffolds that will not cause immune reaction. A:Fully developed products that are decellularized and processed from porcine issues B:Products in development--1. Collagen Implant2. Cartilage Graft3. Collagen Ophthalmic Matrix, Cornea Graft C:Products applied in cell therapy—1.Skin Regeneration. 2.Cartilage Regeneration D:Organ regeneration in development--Customized organs: heart, liver, and kidney
 
Market info
Latest trading info Historic trading info
 
Financial data
Cash flows statement Item
Amount(NTD, in thousands)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Consolidated/Individual
balance sheet
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Consolidated/Individual
profit and loss
statement
Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 Investors may find more detailed information on the company by visiting the Market Observation Post System.。
 The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.